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ABSTRACT

A compact heat exchanger for vena-venous perfusion-induced hyperthermia includes an integral pneumatic pump
and a hollow tubule heat exchange array. A vena-venous
perfusion-induced hyperthermia system incorporating the
compact heat exchanger is described. The heat exchanger
provides a compact, efficient design allowing a lesser heat
exchanging surface area and lesser required pumping power
compared to conventional systems. In turn, the system
provides a shorter blood circuit compared to conventional
systems, allowing maintaining a lower blood temperature
than such conventional systems while supplying sufficiently
heated blood to patient visceral organs to provide a therapeutic effect, such as in supplementing chemotherapy drugs.
11 Claims, 7 Drawing Sheets
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COMPACT HEAT EXCHANGER FOR
VENO-VENOUS PERFUSION-INDUCED
SYSTEMIC HYPERTHERMIA SYSTEMS

includes, a compact heat exchanger including an integral
pneumatic pump and blood flow redirector structures. The
device of the present disclosure provides an even blood flow
pattern, preventing or reducing incidence of thrombosis. In
turn, the presently disclosed design simplifies the blood
circuit and also provides a pulsatile blood flow pattern,
promoting active blood mixing and thereby improving gas
exchange within the pump. The present device finds use at
least as a supplemental therapy for conventional chemotherapy regimens.

This application claims the benefit of priority in U.S.
Provisional Patent Application Ser. Nos. 61/522,411 filed on
Aug. 11, 2011 and 61/651,164 filed on May 24, 2012, the
entirety of the disclosures of each of which are incorporated
herein by reference.
TECHNICAL FIELD
The present invention relates generally to the field of
medical devices. In particular, the invention relates to a
compact heat exchanger for use in vena-venous perfusion
induced systemic hyperthermia (vv-PISH) systems.

10

SUMMARY OF THE INVENTION
15

BACKGROUND OF THE INVENTION
In 2007 lung cancer was responsible for 31% of all
cancer-related deaths. Advanced stage NSCLC present in
7 5% of all new lung cancer cases provides a median survival
rate of only 9-12 months despite maximal combination
chemotherapy. Despite improvements in cancer therapies,
the long-term prognosis for patients with metastatic lung
cancer remains dismal, and indeed chemotherapy provides
only a modest improvement in survival over supportive care
alone.
It has been shown that regional and local hyperthermia
exhibits synergism with various conventional chemotherapy
agents. Hyperthermia selectively kills cancer cells and
enhances cytotoxicity of certain chemotherapy drugs,
increases tumor blood flow and permeability of tumor blood
vessels, and thereby increases drug delivery into a tumor.
For example, hyperthermia enhances platinum uptake and
inhibits platinum-induce DNA adduct repair, an effect that
may be important in reversing cisplatin resistance. Thus,
concurrent combined hyperthermia and chemotherapy has
great potential in advanced NCSCLC therapy.
Because advanced stage NSCLC patients often have
metastasis to remote sites, it is contemplated that systemic
hyperthermia would provide advantages over local hyperthermia. Systemic hyperthermia causes marked physiological changes, but damage to normal tissue occurs when
temperatures exceed 44 C. Heat has a selective killing effect
on malignant phenotypes (lung, colon, and pancreatic cancers, for example) at temperatures between those exhibited
during normal fevers and temperatures that induce tissue
destruction (41-45 C). This suggests that a hyperthermia
therapeutic window may exist for cancer therapy. However,
conventional heat delivery such as radiant heat disadvantageously redistributes blood flow away from visceral organs
to skin, and peripheral tissue, resulting in heterogenous heat
distribution. This leads to insufficient heat delivery to provide a therapeutic benefit, compromising treatment efficiency, and also induces pain and peripheral nerve damage.
In turn, conventional vena-venous perfusion-induced hyperthermia systems, because of their relatively long tubing
lengths and requiring multiple cannulations (increased circuit lengths), must heat blood to unacceptable temperatures
(46 C and above) to provide the desired hyperthermic effect,
risking damage to blood cells and pain to the patient.
To solve this and other problems, the present disclosure
provides a vena-venous perfusion-induced hyperthermia
system (vv-PISH) which delivers more heat to visceral
organs for metastatic cancer treatment while eliminating
complications and disadvantages of radiant heat. The system
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The present disclosure provides a blood heat exchanger
for use as a supplement or replacement therapeutic treatment
to conventional chemotherapy. The heat exchanger includes
an integral pneumatic pump enclosed substantially within a
housing thereof, providing a compact and efficient design.
Inlet blood redirectors and outlet blood collectors are provided, which in combination with the integral pneumatic
pump promote an even perfusion and mixing of blood,
eliminating areas of stagnation and improving heat
exchange.
In an embodiment, an atrium is provided at an inlet of the
blood heat exchanger. The atrium is defined by one or more
additional pneumatic pumps for promoting blood flow from
a patient body into the heat exchanger. By cyclically maintaining an internal pressure of the atrium pneumatic pump(s)
at zero or less, a constant, even supply of blood from the
patient is provided at the blood heat exchanger inlet, thereby
eliminating the pulsatile inlet blood flow patterns provided
by conventional pumping systems.
In turn, a vena-venous perfusion-induced systemic hyperthermia system (vv-PISH) incorporating the heat exchanger
of the present disclosure is described, for removing cooler
blood from a patient body and returning heated blood to
same.
These and other embodiments, aspects, advantages, and
features of the present invention will be set forth in the
description which follows, and in part will become apparent
to those of ordinary skill in the art by reference to the
following description of the invention and referenced drawings or by practice of the invention. The aspects, advantages,
and features of the invention are realized and attained by
means of the instrumentalities, procedures, and combinations particularly pointed out in the appended claims. Unless
otherwise indicated, any references discussed herein are
specifically incorporated by reference in their entirety into
the present disclosure.
BRIEF DESCRIPTION OF THE DRAWINGS

55

60

65

The accompanying drawings incorporated in and forming
a part of the specification, illustrate several aspects of the
present invention, and together with the description serve to
explain the principles of the invention. In the drawings:
FIG. 1 shows a housing for the heat exchanger of the
present disclosure;
FIG. 2 shows a cross-sectional side view of the heat
exchanger
FIG. 3 shows an inlet blood flow redirector for the heat
exchanger;
FIG. 4 shows a top view of the heat exchanger of the
disclosure:
FIG. 5 shows a cross-sectional side view of the heat
exchanger, including an integrated pneumatic pump,

US 9,468,557 B2
3

4

10 towards the blood outlet 16 (see arrows), eliminating
stagnant blood flow in the heat exchanger 10. In turn, a
blood collection channel 32 is provided at a top of the heat
exchanger 10, whereby blood exiting the heat exchanging
5 tubule array 22 is collected and redirected to the blood outlet
16 (see FIGS. 2 and 4). A substantially crescent-shaped
blood collection channel 32 is shown, although the skilled
artisan will appreciate that other cross-sectional shapes are
DETAILED DESCRIPTION OF THE
ILLUSTRATED EMBODIMENTS
possible and contemplated, such as segmental, triangular,
10 etc. The blood collection channel 32 regulates blood flow
evenly at the outlet end of the heat exchanger 10, and further
In the following detailed description of the illustrated
embodiments, reference is made to the accompanying drawguides blood to the blood outlet 16. That is, blood enters via
the blood inlet 14 and is evenly redirected by the inlet blood
ings that form a part hereof, and in which is shown by way
of illustration, specific embodiments in which the invention
flow redirector 28 as summarized above to pass over the heat
may be practiced. These embodiments are described in 15 exchanging tubule array 22. On exiting the heat exchanging
tubule array 22, blood passes into the blood collection
sufficient detail to enable those skilled in the art to practice
the invention. Also, it is to be understood that other embodichannel32 and therefrom exits the heat exchanger 10 via the
ments may be utilized and that process, reagent, software,
blood outlet 16. In that manner, areas of stagnant blood flow
and/or other changes may be made without departing from
at or near the blood outlet 16 are reduced or eliminated.
the scope of the present invention.
20
In turn, a blood collection channel 32 is provided at a top
of the heat exchanger 10, whereby blood exiting the heat
In one aspect, the present disclosure provides a compact
exchanging tubule array 22 is collected and redirected to the
heat exchanger 10 (see FIG. 1) including a housing 12, at
least one blood inlet 14, and at least one blood outlet 16. At
blood outlet 16 (see FIGS. 2 and 4). A substantially crescentleast one heated fluid inlet 18 and at least one heated fluid
shaped blood collection channel 32 is shown, although the
outlet 20 are provided for supplying a heated fluid to and 25 skilled artisan will appreciate that other cross-sectional
removing same from the heat exchanger 10, typically with
shapes are possible and contemplated, such as segmental,
the heated fluid being passed through a hollow heat
triangular, ect. The blood collection channel 32 regulates
blood flow evenly at the outlet end of the heat exchanger 10,
exchanging tubule array 22 of the heat exchanger 10 in a
and further guides blood to the blood outlet 16. That is,
counter-current direction compared to that of the blood flow.
The heat exchanging tubule array 22 may be fabricated of 30 blood enters via the blood inlet 14 and is evenly redirected
any suitable heat exchanging metal. In an embodiment, the
by the inlet blood flow redirector 28 as summarized above
tubules of the heat exchanging tubule array 22 are fabricated
to pass over the heat exchanging tubule array 22. On exiting
of 0.2 mm thick stainless steel tubing and provide approxithe heat exchanging tubule array 22, blood passes into the
mately 0.095-0.113 m 2 of total heat exchanging surface.
blood collection channel 32 and therefrom exits the heat
As shown in FIG. 2, arrays 22 of heat exchanging tubules 35 exchanger 10 via the blood outlet 16. In manner, areas of
may be provided arranged substantially parallel to a longistagnant blood flow at or near the blood outlet 16 are
tudinal axis of the heat exchanger 10 housing 12, or alterreduced or eliminated.
natively diagonal spirally wound heat exchanging tubule
Rather than utilizing an external pump as is common with
arrays 22 (not shown) may be provided. Inlet potting 24 and
conventional heat exchangers, the heat exchanger 10 of the
outlet potting 26, known in the art, is provided and disposed 40 present disclosure includes an integral pneumatic pump to
to prevent entry of blood into the lumens of the hollow heat
provide pumping action for passing blood from the blood
exchanging tubules of the heat exchanging tubule array 22
inlet 14, over the heat exchanging tubule array 22, and to the
blood outlet 16. As such, a compact, economical and effiand direct mixing with the heated fluid contained therein.
The inlet potting 24 may define an inverted dome shape,
cient combination of pump and heat exchanger is provided.
further assisting in promoting even redistribution of blood 45 Providing further advantages, the integral pneumatic pump
passing through the heat exchanger 10. The inlet potting 24
provides a pulsatile blood flow pattern, promoting active
may define an inverted dome shape, further assisting in
blood mixing as the blood passes through the heat exchanger
promoting even redistribution of blood passing through the
10, for improved heat exchange performance and an
heat exchanger 10.
improved blood flow pattern to reduce thrombogenicity.
The system 10 of the invention further includes blood 50 Because of that improved gas exchange performance, it is
flow redirector structures, providing an even blood flow
possible to provide a lesser heat exchange surface area
pattern as blood passes through the heat exchanger 10. An
compared to conventional heat exchangers, allowing a more
inlet blood flow redirector 28 is provided at an end of the
compact unit.
heat exchanger 10 distal from the blood inlet 14 for evenly
With reference to FIG. 5, a cylinder 34 is disposed in an
redirecting blood flow passing through the blood inlet 14. In 55 interior of the heat exchanging tubule array 22, Within
an embodiment, a frusta-conical inlet blood flow redirector
cylinder 34, a flexible membrane 36 is disposed to define a
28 is provided at a distal end of the blood inlet 14 (see FIG.
pneumatic pump 38. Pump inlet and outlet valves 40, 42, in
an embodiment being duck-bill valves of known configu3), secured to or molded with the distal end of the blood inlet
14 by one or more columns 30. At least a portion of the
ration, prevent other than a uni-directional blood flow
conical inlet blood flow redirector 28 is disposed in an 60 through the pneumatic pump 38 (see arrows).
interior of the blood inlet 14 distal end. Like structures are
A pump gas inlet/outlet 44 is connected to a pneumatic
described in U.S. Pat. No. 8,906,300, filed concurrently
console (not shown) for providing gas to operate the pneuherewith and incorporated herein in its entirety by reference.
matic pump 38. Pump gas is cyclically supplied to and
As shown in FIG. 2, the inlet blood flow redirector 28
withdrawn from the pump gas inlet/outlet 44, causing the
promotes even radial perfusion across a surface of the inlet 65 flexible membrane 36 to expand and contract, providing a
potting 24 at a bottom of the heat exchanger and also even
pumping action to promote blood flow. As shown in FIGS.
2 and 5, when gas is supplied to the pump gas inlet/outlet 44
axial blood flow as blood travels through the heat exchanger
FIGS. 6a and 6b show the heat exchanger including an
atrium, in diastolic phase (FIG. 6a) and in systolic phase
(FIGS. 6b); and
FIG. 7 graphically depicts relative internal pressures of
the atrium and heat exchanger in systolic and diastolic
phases.
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(systole), the flexible membrane 36 collapses, closing the
pump inlet valve 40 and forcing blood out of the pneumatic
pump 38 via the now open outlet valve 42 to pass over the
heat exchanging tubule array 22. When gas is withdrawn
from the pump gas inlet/outlet 44 (diastole), the flexible
membrane 36 expands, closing the pump outlet valve 42 and
opening the pump inlet valve 40, generating negative pressure and drawing blood into the pneumatic pump 38 from
the patient's body through the now-open pump inlet valve
40 (FIG. 5). On the next cycle, the blood is delivered from
the pneumatic pump 38 as described above.
In an embodiment, a heat exchanger 10 was fabricated
having an integral pneumatic pump 38 with an outer diameter of approximately 20 mm. In bench tests using 37%
glycerin in a mock blood flow circuit, this device was shown
to provide a pumping rate of from 1.251 Llmin at 40 beats
per minute to 3.2 Llmin at 90 beats per minute against 100
mm Hg afterload, which was more than sufficient to meet a
benchmark of 1-1.5 Llmin. Heat exchange efficiency for this
device was above 70% at a flow rate of 1-1.5 Llmin.
By the foregoing design, a heat exchanger 10 is possible
which provides a desired circuit blood flow rate of 0.5-2.0
Llmin, an therapeutic hyperthermia dose of 42 C for 120
min, a heating period of less than 40 minutes, an infusion
blood temperature of 44 C or less, and stable hemodynam-

negative and blood is almost always draining from the
patient and into the atrium. In turn, very little resistance is
imposed to transfer of blood from the atrium 100 into the
heat exchanger 10 to fill the pneumatic pump 38, since when
pump gas is withdrawn from the heat exchanger 10 pneumatic pump 38 (diastole, see FIGS. 6a and 7), the internal
pressure of the atrium 100 is zero at its highest, i.e. slightly
higher than the internal pressure of the heat exchanger 10
pneumatic pump 38. By this mechanism, transfer of blood
from the atrium 100 to the heat exchanger 10 pneumatic
pump 38 is promoted by that slight pressure differential.
These differentials are shown graphically in FIG. 7. Of
course, the more even and non-pulsatile blood flow pattern
established between the atrium 100 and the heat exchanger
10 achieved by the present mechanism should not be confused with the pulsatile flow established for blood passing
through the heat exchanger 10 via the heat exchanger
pneumatic pump 38, for the benefits described above.
The present heat exchanger 10 will typically be supplied
with blood from a patient's body by a carmula. A dual lumen
carmula such as those described in U.S. Pat. No. 7,473,239
and/or U.S. Published PatentAppl. No. US 2011/0040241 is
preferred, which both passes blood from a patient's body via
a withdrawal carmula into the oxygenator 10 and passes
blood back into the patient's body via a delivery cannula.
The dual lumen cannula may be inserted through a small
incision into the right jugular vein, via the superior vena
cava and traversing the right atrium, with the tip positioned
in the inferior vena cava. This has the further advantage of
reducing the length of the defined blood flow circuit and
thereby the length of the vv-PISH circuit, reducing the
length of time blood is exposed to potentially damaging heat
and also the amonnt of heat required to raise the blood
temperature to a desired level, and further eliminates multiple and potentially dangerous (to the patient)cannulations.
In combination with the pump-integrated heat exchanger 10
of the present disclosure, use of a dual lumen cannula allows
shortening the vv-PISH circuit to lfw'h that of prior art
systems. Blood contact surface area, circuit resistance, and
circuit heat loss are significantly reduced, improving efficiency, reliability, and performance.
An electronically controlled pneumatic console may be
provided to drive the above-described pneumatic pump 38.
Because the pump-integrated heat exchanger 10 includes a.
pneumatic pump 38 of lesser capacity than is needed to drive
a conventional heat exchanger, a more compact pneumatic
console is possible.
There is accordingly provided by the present disclosure a
compact, efficient heat exchanger 10 which provides a
pulsatile, evenly dispersed blood flow therethrough, augmenting heat exchange performance and in turn allowing a
lessened heat exchange surface area providing a necessary
level of heating of blood, to allow a more compact and
efficient design. The heat exchanger 10 may include an
atrium 100 defined by one or more additional pneumatic
pumps 102, for regulating and providing an even blood
supply from a patients'circulatory system into the heat
exchanger 10. The heat exchanger 10 finds use in a variety
of procedures, including supplementing conventional cancer
chemotherapy regimens. Unlike conventional heat
exchanger designs, the present heat exchanger 10 reduces or
eliminates regions of stagnant or limited blood flow leading
to thrombosis and device occlusion/failure, and further provides a pulsatile flow which also decreases stagnant blood
flow and reduces thrombogenicity.
In turn, the integrated pump design of the heat exchanger
10 eliminates connectors and tubing such as are found in
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In another aspect, an atrium 100 is provided which further
improves blood flow through the heat exchanger 10 of the
present disclosure (see FIGS. 6a and 6b). In an embodiment,
the atrium 100 is defined by at least one additional pneumatic pump 102, disposed at or defining the blood inlet of
the heat exchanger 10. As shown the at least one additional
pneumatic pump 102 is configured substantially as described
above for the integral pneumatic pump 38 of the heat
exchanger 10, including a pneumatic cylinder 104 and
flexible membrane 106, and a gas inlet/outlet 108. For
convenience and compactness, the atrium outlet valve may
define the inlet valve 40 for the heat exchanger 10 integrated
pneumatic pump 38, although of course the valve structures
may be entirely separate.
The atrium 100 operates in systolic and diastolic phases as
described for the heat exchanger 10 pneumatic pump 38.
That is, cyclically supplying gas to the gas inlet/outlet 108
causes the atrium pneumatic pump 102 flexible membrane
106 to expand and collapse. passing blood through the
pneumatic pump 102 and into the heat exchanger 10.
In use, the atrium 100 is kept primarily in a state of
negative internal pressure by withdrawal of gas, with the
exception of a time immediately prior to the diastolic phase
of the heat exchanger 10 pneumatic pump 38 (see FIG. 7).
Typically, the atrium 100 internal pressure is substantially
zero at the highest, i.e. during diastole. This is accomplished
by intermittently discontinuing withdrawal of gas from the
atrium 100 (as distinguished from affirmatively supplying
gas to the atrium 100 pneumatic pump 102). In contrast, the
heat exchanger 10 pneumatic pump 38 is provided only a
very short phase of negative internal pump pressure (see
FIG. 7). In diastole, when an internal pressure of the atrium
100 pneumatic pump 102 is highest, an internal pressure of
the heat exchanger 10 pneumatic pump 38 is made slightly
negative by withdrawal of gas (see FIG. 7).
By this design, the skilled artisan will appreciate that a
consistent flow of blood is established into the inlet of the
heat exchanger 10 compared to the pulsatile and irregular
entry of blood into heat exchangers established by conventional designs. This is because the internal pressure of the
atrium 100 into which blood first flows is almost always
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conventional heat exchanger/non-integral pump designs,
reducing resistance to blood flow and improving pump
performance. The combined integrated pump/heat
exchanger lung design simplifies and shortens the vv-PISH
circuit in that only one component is provided in the circuit,
and further increases pump efficiency by eliminating blood
flow resistance from connections between the pump and the
artificial lung.
One of ordinary skill in the art will recognize that addi10
tional embodiments of the invention are also possible without departing from the teachings herein. For example, the
above-described vv-PISH system may optionally include a
dialysis unit (not shown) for use in patients with compromised kidney function. The dialysis unit may he connected 15
via connectors (not shown) on the heat exchanger 10 blood
inlet/outlet. Advantageously, the pressure gradient created
by the heat exchanger 10 will drive up to 30% of the circuit
blood flow (recirculation) through the dialysis unit, without
requiring additional external pumps.
20
This detailed description, and particularly the specific
details of the exemplary embodiments, is given primarily for
clarity of understanding, and no unnecessary limitations are
to be imported, for modifications will become obvious to
those skilled in the art upon reading this disclosure and may 25
be made without departing from the spirit or scope of the
invention. Relatively apparent modifications, of course,
include combining the various features of one or more
figures or examples with the features of one or more of other
figures or examples.
30
What is claimed is:
1. A compact heat exchanger for vena-venous perfusioninduced hyperthermia, comprising:
a housing, a blood inlet ending at a distal-most surface of
the compact heat exchanger and defining a longitudinal
axis, a blood outlet, a heated fluid inlet, and a heated
fluid outlet;
a hollow tubule heat exchange array disposed within an
interior of the housing for heat exchange to and from
blood passing through the compact heat exchanger;
an inlet blood flow redirector disposed at a distal-most
end of the blood inlet and configured to redirect a flow
of the blood radially to the longitudinal axis across the
compact heat exchanger distal-most surface and therefrom to the hollow tubule heat exchange array, the
blood perfusing therefrom to the blood outlet; and
a pneumatic pump disposed substantially within the blood
inlet and within a perimeter defined by the housing,
further wherein the pneumatic pump is disposed in an
interior of the hollow tubule heat exchange array.
2. The heat exchanger of claim 1, wherein the pneumatic
pump provides a blood flow rate of from about 0.5 to about
2 Llminute.
3. The heat exchanger of claim 2, wherein a heat exchanging surface area of the hollow tubule heat exchange array is
optimal for heating the blood passing therethrough at a flow
rate of from about 0.5 to about 2 Llminute to a blood
temperature of up to 44 C for delivery to a patient body.
4. The heat exchanger of claim 1, wherein the hollow
tubule heat exchange array is fabricated of a suitable heat
exchanging metal.
5. The heat exchanger of claim 4, wherein the suitable
heat exchanging metal is stainless steel.
6. A vena-venous perfusion-induced hyperthermia systern, comprising:
a compact heat exchanger comprising:
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a housing, a blood inlet ending at a distal-most surface
of the compact heat exchanger and defining a longitudinal axis, a blood outlet, a heated fluid inlet, and
a heated fluid outlet;
a hollow tubule heat exchange array disposed within an
interior of the housing for heat exchange to and from
blood passing through the compact heat exchanger;
an inlet blood flow redirector disposed at a distal-most
end of the blood inlet and configured to redirect a
flow of the blood radially to the longitudinal axis
across the compact heat exchanger distal-most surface and therefrom to the hollow tubule heat
exchange array, the blood perfusing therefrom to the
blood outlet; and
a pneumatic pump disposed substantially within the
blood inlet and within a perimeter defined by the
housing, further wherein the pneumatic pump is
disposed in an interior of the hollow tubule heat
exchange array;
a pneumatic console for cyclically supplying and withdrawing gas to and from the compact heat exchanger
to operate the pneumatic pump and thereby pass the
blood over the compact heat exchanger hollow
tubule heat exchange array;
another pump for passing heated fluid through the
compact heat exchanger hollow tubule heat
exchange array;
and a dual lumen cannula for withdrawing the blood
from a patient body, passing the blood through the
compact heat exchanger, and returning the blood to
the patient body.
7. The vena-venous perfusion-induced hyperthermia system of claim 6, wherein the pneumatic console and pneumatic pump provide a blood flow rate of from about 0.5 to
about 2 Llminute.
8. The vena-venous perfusion-induced hyperthermia system of claim 7, wherein a heat exchanging surface area of
the hollow tubule heat exchange array is optimal for heating
the blood passing therethrough at a flow rate of from about
0.5 to about 2 Llminute to a blood temperature of up to 44
C for delivery to a patient body.
9. The vena-venous perfusion-induced hyperthermia system of claim 8, wherein the hollow tubule heat exchange
array is fabricated of a suitable heat exchanging metal.
10. The vena-venous perfusion-induced hyperthermia
system of claim 9, wherein the suitable heat exchanging
metal is stainless steel.
11. A compact heat exchanger for vena-venous perfusioninduced hyperthermia, comprising:
a housing, a blood inlet ending at a distal-most surface of
the compact heat exchanger and defining a longitudinal
axis, a blood outlet, a heated fluid inlet, and a heated
fluid outlet;
a hollow tubule heat exchange array disposed within an
interior of the housing for heat exchange to and from
blood passing through the compact heat exchanger;
an inlet blood flow redirector disposed at a distal-most
end of the blood inlet, the inlet blood flow redirector
including a conical tip extending into an interior lumen
of the distal-most end of the blood inlet for evenly
dispersing the blood radially to the longitudinal axis
across the compact heat exchanger distal-most surface
and therefrom to the hollow tubule heat exchange array,
the blood perfusing therefrom to the blood outlet; and
a pneumatic pump disposed substantially within the blood
inlet and within a perimeter defined by the housing,
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further wherein the pneumatic pump is disposed in an
interior of the hollow tubule heat exchange array.
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